Butyl Alcohol

Butyl Alcohol

SCHEMBL352043

CC(C)=O.CCCCO.CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.69
SMN1; SMN2 Q16637 1/20 0.56
LMNA P02545 2/20 0.53
TSHR P16473 2/20 0.53
HSD17B10 Q99714 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CES1 P23141 6/20 0.43
CES2 O00748 5/20 0.43
AKR1B1 P15121 1/20 0.39
TP53 P04637 1/20 0.39
NAAA Q02083 1/20 0.38
GPR84 Q9NQS5 2/20 0.38
PPARG P37231 2/20 0.38
PPARD Q03181 2/20 0.38
PPARA Q07869 2/20 0.38
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
TLR2 O60603 1/20 0.38
HDAC11 Q96DB2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyl Alcohol SCHEMBL27685696 0.97 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL27390375 0.97 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL148760 0.97
Butyl Alcohol SCHEMBL27615272 0.97 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL27587645 0.94 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL7102169 0.94 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Hexane SCHEMBL28594592 0.94 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL28258914 0.94 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL4103938 0.94 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL65184 0.94 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435571-B2 Extracts and compounds from “Agapanthus africanus” and their use as biological plant protecting agents Afrarforum AG (DE) 2013-05-07 US disclosed
US-20120015062-A1 EXTRACTS AND COMPOUNDS FROM \"AGAPANTHUS AFRICANUS\" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS AGRARFORUM SA (PTY) LTD. (ZA) 2012-01-19 US disclosed
US-20090258097-A1 EXTRACTS AND COMPOUNDS FROM \"AGAPANTHUS AFRICANUS\" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS AGRARFORUM AG (DE) 2009-10-15 US disclosed
US-7576240-B2 Arylamine processes XEROX CORPORATION (US) 2009-08-18 US disclosed
US-20070254225-A1 ARYLAMINE PROCESSES XEROX CORPORATION (US) 2007-11-01 US disclosed
US-7196214-B2 Process for arylamine production XEROX CORPORATION (US) 2007-03-27 US disclosed
US-20060111582-A1 Process for arylamine production XEROX CORPORATION (US) 2006-05-25 US disclosed
EP-0632003-B1 Novel phenol compounds containing methoxymethyl group or hydroxymethyl group FUJI PHOTO FILM CO LTD (JP) 1998-01-14 EP disclosed
US-5488182-A CROSSLINKERS FOR PHENOLIC RESINS FUJI PHOTO FILM CO., LTD. (JP) 1996-01-30 US disclosed
EP-0632003-A1 Novel phenol compounds containing methoxymethyl group or hydroxymethyl group FUJI PHOTO FILM CO., LTD. (JP) 1995-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254225-A1 ARYLAMINE PROCESSES HNMT, AHR, INMT ALDH1A1 384/4885SMN1; SMN2 3584/4885LMNA 4762/4885
US-20090258097-A1 EXTRACTS AND COMPOUNDS FROM \"AGAPANTHUS AFRICANUS\" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS GGT1, AGPS, NPEPPS ALDH1A1 2004/4885SMN1; SMN2 4387/4885LMNA 3540/4885
US-20120015062-A1 EXTRACTS AND COMPOUNDS FROM \"AGAPANTHUS AFRICANUS\" AND THEIR USE AS BIOLOGICAL PLANT PROTECTING AGENTS GGT1, AGPS, NPEPPS ALDH1A1 2004/4885SMN1; SMN2 4387/4885LMNA 3540/4885
US-20060111582-A1 Process for arylamine production AOC2, UFM1, TYR ALDH1A1 1029/4885SMN1; SMN2 3194/4885LMNA 2621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.